Use of allulose or erythritol in improving gut microbiota and medicine
By applying a combination of allulose and erythritol, the colonic bacterial communities of Trichophytonceae and Euglenophyceae were increased, which solved the problem of the impact of high sugar intake on the gut microbiota, especially the problem of insufficient butyrate production, and achieved the effects of improving gut health and preventing diseases.
CN122249204APending Publication Date: 2026-06-19TATE & LYLE SOLUTIONS USA LLC
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- TATE & LYLE SOLUTIONS USA LLC
- Filing Date
- 2024-10-18
- Publication Date
- 2026-06-19
AI Technical Summary
⚠Technical Problem
Existing technologies have not effectively addressed the impact of high sugar intake on the gut microbiota, particularly the problem of insufficient butyrate production in patients with type 2 diabetes. Furthermore, current probiotic products do not perform well in surviving and competing in the gut environment.
⚗Method used
A combination of allulose and erythritol, administered orally, increases the colonic bacterial community of Trichophyton and Eurybacterium species, promoting the production of short-chain fatty acids.
🎯Benefits of technology
It increases the number of beneficial bacteria in the gut, enhances butyrate production, improves the health of the gut microbiota, and has potential disease prevention and treatment effects.
✦ Generated by Eureka AI based on patent content.
Abstract
Methods for improving the gut microbiota of a subject, increasing one or more bacterial communities belonging to the Helicobacterium or Euglobulaceae families in their colonic flora, for the prevention, treatment, or relief of disease, and for increasing the level of short-chain fatty acids in the colon, comprising administering to the subject a composition containing allulose, erythritol, or a combination thereof. The composition used in the above methods comprises allulose, erythritol, or a combination thereof. The composition comprises allulose, erythritol, or a combination thereof, and one or more colonic bacterial communities from the Helicobacterium or Euglobulaceae families.
Need to check novelty before this filing date? Find Prior Art